Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report (original) (raw)

References

  1. Rubie H, Benoit Y, Behar C, Lutz P, Maurus R, Philippe N, Plouvier E, Robert A, Sauveur E, Solbu G, Suciu S, Otten J . Treatment of standard risk (SR) acute lymphoblastic leukemia (ALL) with the BFM protocol with or without cyclophosphamide: preliminary results of a randomized trial (EORTC nr 58831). SIOP XX Meeting, Trondheim, Norway, 22–26 August 1988
  2. Benoit Y, Boilletot A, Francotte N, Hoyoux C, Marguerite G, Philippe N, Souillet G, Thyss A, Solbu G, Suciu S, Otten J . Treatment of medium and high risk (M-HR) acute lymphoblastic leukemia (ALL) with or without radiotherapy (RXT): results of a randomized trial (EORTC nr 58832). SIOP XX Meeting, Trondheim, Norway, 22–26 August 1988
  3. Millot F, Suciu S, Philippe N, Benoit Y, Nelken B, Uyttebroeck A, Mechinaud F, Vilmer E, Robert A, Boutard P, Marguerite G, Ferster A, Plouvier E, Rialland X, Behar C, Plantaz D, Dresse MF, Philippet P, Waterkeyn C, Otten J . Value of high dose Ara-C during the interval-therapy of a BFM like protocol in increased risk ALL and NHL stage III and IV patients: results of the EORTC 58881 trial Blood 1999 94: (Suppl. 1) (Abstr. 1700)
  4. Millot F, Suciu S, Philippe N, Benoit Y, Mazingue F, Uyttebroeck A, Mechinaud F, Vilmer E, Robert A, Boutard P, Marguerite G, Ferster A, Plouvier E, Rialland X, Behar C, Plantaz D, Dresse MF, Philippet P, Waterkeyn C, Otten J for the Children Leukemia Cooperative Group (CLCG) of the European Organization for Research and Treatment of Cancer (EORTC) . Value of high-dose Ara-C during the interval-therapy of a BFM-based protocol in increased risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the EORTC 58881 randomized phase III trial. (Submitted)
  5. Van Der Werften Bosch J, Suciu S, Philippe N, Mazingue F, Vilmer E, Robert A, Mechinaud F, Marguerit G, Lutz P, Ferster A, Boutard P, Brock P, Muntzer M, Michel G, Plouvier E, Rialland X, Thyss C, Waterkeyn C, Solbu G, Otten J . The value of 6-MP i.v. during maintenance treatment in childhood acute lymphoblastic leukemia (ALL) and non Hodgkin lymphoma (NHL): results of the randomized phase III trial 58881 of EORTC Childhood Leukemia Cooperative Group (CLCG) Blood 1999 94: (Suppl. 1) (Abstr. 2791)
  6. Otten J, Suciu S, Lutz P, Benoit Y, Robert A, Thyss A, Plouvier E, Ferster A, Mechinaud F, Mazingue F, Brock P, Vilmer E, Solbu G, Waterkeyn C, Philippe N, Van Camp B . The importance of L-asparaginase (A'ase) in the treatment of acute lymphoblastic leukemia (ALL) in children Blood 1996 88: (Suppl. 1) (Abstr. 2633)
  7. Duval M, Suciu S, Ferster A, Benoit Y, Francotte N, Dresse MF, Uyttebroeck A, Plouvier E, Thyss A, Lutz P, Marguerite G, Behar C, Mazingue F, Boutard P, Millot F, Rialland X, Mechinaud F, Norton L, Robert A, Waterkeyn C, Vilmer E, Philippe N, Otten J . Comparative toxicity and efficacy of _E. coli_-asparaginase and Erwinia-asparaginase in childhood lymphoid malignancies: results of an EORTC-CLCG phase III randomized trial. (Submitted)
  8. Langerman HJ, Henze G, Wulf M, Rhiem H . Abschatzung der tumorzellmasse bei der akuten lymphoblastischen leukamie im kindesalter: prognostische bedeuting und pratische Anwendung Klin Ped 1982 194: 209–213
    Article Google Scholar
  9. Schrappe M, Reiter A, Ludwig WD, Harbott J, Zimmermann M, Hiddeman W, Niemeyer C, Henze G, Feldges A, Zint F, Kormhuber B, Riter J, Welte K, Gadner H, Riehm H . Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90 Blood 2000 95: 3310–3322
    CAS PubMed Google Scholar
  10. Mahmoud HH, Rivera GK, Hancock ML, Krance RA, Kun LE, Behm FG, Ribeiro RC, Sandlund JT, Crist WM, Pui CH . Low leucocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia New Engl J Med 1993 329: 314–319
    Article CAS PubMed Google Scholar
  11. Henze G, Buchmann S, Fengler R, Hartmann R . The BFM relapse studies in childhood ALL: concepts of two multicenter trials and results after 2½ years Hamatol Bluttransfus 1987 30: 147–155
    CAS Google Scholar
  12. Harris EK, Albert A . Survivorship Analysis for Clinical Studies M Dekker: New York 1991
    Google Scholar
  13. Gardner MJ, Altman DG . Statistics with Confidence – Confidence Intervals and Statistical Guidelines British Medical Journal: London 1989
    Google Scholar
  14. Thyss A, Suciu S, Bertrand Y, Mazingue F, Robert A, Vilmer E, Mechinaud F, Benoit Y, Brock P, Ferster A, Lutz P, Boutard P, Marguerite G, Plouvier E, Michel G, Plantaz D, Munze M, Rialland X, Chantraine JM, Norton L, Solbu G, Philippe N, Otten J . Systemic effect of intrathecal methotrexate during the initial phase of treatment of childhood acute lymphoblastic leukemia J Clin Oncol 1997 15: 1824–1830
    Article CAS PubMed Google Scholar
  15. Cavé H, Van Der Werff Ten Bosch J, Suciu S, Guidal C, Waterkeyn C, Otten J, Bakkus M, Thielemans K, Grandchamp B, Vilmer E . Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia New Engl J Med 1998 339: 591–598
    Article PubMed Google Scholar
  16. Ferster A, Benoit Y, Francotte N, Dresse MF, Uyttebroeck A, Plouvier E, Thyss A, Lutz P, Marguerite G, Behar C, Mazingue F, Boutard P, Millot F, Rialland X, Mechinaud F, Norton L, Robert A, Otten J, Vilmer E, Philippe N, Waterkeyn C, Suciu S . Treatment outcome in infant acute lymphoblastic leukemia Blood 2000 95: 2729–2731
    Article CAS PubMed Google Scholar
  17. Reiter A, Schrappe M, Ludwig WD, Hiddemann W, Sauter S, Henze G, Zimmermann M, Lampert F, Havers W, Niethammer D, Odenwald E, Ritter J Mann G, Welte K, Gadner H, Riehm H . Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia. Results and conclusions of the multicenter trial ALL-BFM 86 Blood 1994 84: 3122–3133
    Article CAS PubMed Google Scholar
  18. Guidal C, Vilmer E, Grandchamp B, Cavé H . A semi-quantitative method using TcRγδ and IgH rearrangements for rapid detection of patients with high levels of minimal residual disease in acute lymphoblastic leukemia. (Submitted)
  19. Loning L, Zimmermann M, Reiter A, Kaatsch P, Henze G, Riehm H, Schrappe M . Secondary neoplasms subsequent to Berlin–Frankfurt–Munster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy Blood 2000 95: 2770–2275
    Article CAS PubMed Google Scholar
  20. Pui CH, Mahmoud HH, Rivera GK, Hancock ML, Sandlund JT, Behm FG, Head DR, Relling MV, Ribeiro RC, Rubnitz JE, Kun LE, Evans WE . Early intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukemia Blood 1998 92: 411–415
    Article CAS PubMed Google Scholar
  21. Conter V, Shrappe M, Arico M, Reiter A, Rizzori C, Dordelmann M, Valsecchi MG, Zimmermann M, Ludwig WD, Basso G, Masera G, Riehm H . Role of cranial radiotherapy for chilhood T-cell acute lymphoblastic leukemia with high WBC count and good response to prednisone J Clin Oncol 1997 15: 2786–2791
    Article CAS PubMed Google Scholar
  22. Graham ML, Shuster JJ, Kamen BA, Land VJ, Borowitz MJ, Camitta B, Cheo DL, Harrison MP, Leventhal BG, Pinkel DP, Pullen DJ, Steuber P, Whitehead VM . Changes in red blood cell methotrexate pharmacology and their impact on outcome when cytarabine is infused with methotrexate in the treatment of acute lymphocytic leukemia in children: a Pediatric Oncology Group study Clin Cancer Res 1996 2: 331–337
    CAS PubMed Google Scholar
  23. Relling MV, Hancock ML, Boyett JM, Pui CH, Evans WE . Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia Blood 1999 93: 2817–2823
    Article CAS PubMed Google Scholar
  24. Asselin BL, Whitin JC, Coppola DJ, Rupp IP, Sallan SE, Cohen HJ . Comparative pharmacokinetics studies of three asparaginase preparations J Clin Oncol 1993 11: 1780–1786
    Article CAS PubMed Google Scholar
  25. Boos J, Weber G, Ahlke E, Schulze WP, Nowak GO, Wurthwein G, Boos J, Werber G, Ahlke E, Schulze-Westhoff P, Nowak-Gottl U, Wurthwein G, Verspohl EJ, Ritter J, Jurgens H . Monitoring of asparaginase activity and asparaginase levels in children on different asparaginase preparations Eur J Cancer 1996 32A: 1544–1550
    Article CAS PubMed Google Scholar

Download references